Status:
ACTIVE_NOT_RECRUITING
Identification and Management of Comorbidities and Extra-intestinal Manifestations in Crohn's Disease: the NEMO Nurse-led Program
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Crohn Disease
Eligibility:
All Genders
18-59 years
Phase:
NA
Brief Summary
Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal (GI) tract. Although inflammation is predominantly expressed in the GI tract, extra-intestinal manifestations (EIMs) are ...
Eligibility Criteria
Inclusion
- Established diagnosis of CD with a minimum disease duration of 3 months
- CD considered by the treating gastroenterologist to have been stable for at least 3 months
- No surgery planned within 6 months after the inclusion visit
Exclusion
- Subject unable to attend all the study visits or comply with study procedures.
- Subject unwilling or not able to understand or sign the informed consent.
Key Trial Info
Start Date :
December 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT05254886
Start Date
December 12 2022
End Date
January 1 2027
Last Update
May 6 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Nancy University Hospital
Vandœuvre-lès-Nancy, France
2
San Raffaele Hospital
Milan, Italy